ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc.

January 05, 2011 06:00 ET

ProMetic to Present at Biotech Showcase 2011

MONTREAL, QUEBEC--(Marketwire - Jan. 5, 2011) - ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") today announced that Mr. Pierre Laurin, President and Chief Executive Officer, will be giving a corporate presentation at the upcoming Biotech Showcase 2011 conference. Mr. Laurin will be speaking on Wednesday, January 12, 2011, at 10:15 (PST) in the Stockton Room of the Parc 55 Wyndham San Francisco – Union Square, San Francisco, California, USA.

A live audio webcast of the presentation will be available through ProMetic's website at

About Biotech Showcase 2011

Biotech Showcase 2011 (, which is focused on biotechnology, provides private and public presenting companies an opportunity to present to an audience of investors and biopharmaceutical business development executives.

About ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. ("ProMetic") ( is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand™ technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of hematology and cancer. Its drug discovery platform is focused on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montréal (Canada), ProMetic has R&D facilities in the U.K., the U.S. and Canada, manufacturing facilities in the U.K. and business development activities in the US, Europe, Asia and in the Middle-East.

Contact Information

  • ProMetic Life Sciences Inc.
    Pierre Laurin
    President and CEO
    ProMetic Life Sciences Inc.
    Anne Leduc
    Manager, Investor Relations & Communications